Metabolomics Reveals that Hepatic Stearoyl-CoA Desaturase 1 Downregulation Exacerbates Inflammation and Acute Colitis-Reference-Cited by-同舟云学术

Metabolomics Reveals that Hepatic Stearoyl-CoA Desaturase 1 Downregulation Exacerbates Inflammation and Acute Colitis

Published:2008-02 Issue:2 Volume:7 Page:135-147
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Chen Chi,Shah Yatrik M.,Morimura Keiichirou,Krausz Kristopher W.,Miyazaki Makoto,Richardson Terrilyn A.,Morgan Edward T.,Ntambi James M.,Idle Jeffrey R.,Gonzalez Frank J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference58 articles.

1. Mediterranean diet and health: biological importance of olive oil;Alarcon de la Lastra;Curr. Pharm. Des.,2001

2. Discovering the cause of inflammatory bowel disease: lessons from animal models;Arseneau;Curr. Opin. Gastroenterol.,2000

3. Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C;Asaoka;Proc. Natl. Acad. Sci. USA,1992

4. Albumin stimulates the release of lysophosphatidylcholine from cultured rat hepatocytes;Baisted;Biochem. J.,1988

5. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands;Baker;J. Biol. Chem.,2005

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linoleoyl-lysophosphatidylcholine suppresses immune-related adverse events due to immune checkpoint blockade;2024-08-08

2. Unraveling the causal link: fatty acids and inflammatory bowel disease;Frontiers in Immunology;2024-07-25

3. Faecal Short-Chain, Long-Chain, and Branched-Chain Fatty Acids as Markers of Different Chronic Inflammatory Enteropathies in Dogs;Animals;2024-06-19

4. The powerful potential of amino acid menthyl esters for anti‐inflammatory and anti‐obesity therapies;Immunology;2024-05-08

5. SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors;Biomedicine & Pharmacotherapy;2024-01